Neumora Therapeutics
established proof of concept for treatment of depression and anhedonia in patients with moderate to severe | Neumora Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2023
Slide
10 of 32
Related slides by other companies
Erasca
Investor Presentation
November 2023
phase patients continuing on treatment on potential for confirmation of dor and advantage in seacraft | Erasca
BioAtla
Investor Presentation
January 2024
phase cab demographics tumor types | BioAtla
Compass Therapeutics
Investor Presentation
May 2023
patient demographics and current treatments | Compass Therapeutics
Compass Therapeutics
Investor Presentation
February 2023
patient demographics and current treatments | Compass Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io